EOLS Evolus Inc: Rasio total nilai perusahaan marang pendapatan

evolus.com (EOLS) - logo korporat

Evolus, Inc. (EOLS) generates revenue from the sale of its high-margin Jeuveau neurotoxin for aesthetic correction. However, reliance on a single counterparty and industry price wars create risks for profitability. The company's EV/Sales multiple helps assess the risk of a drawdown, with the current level standing at 1804.19. Growing brand popularity among youth and the launch of new fillers are driving further revenue growth.

Evolus, Inc. - Multiplikator EV/Sales EOLS (periode 23.11.2025 - 20.11.2026)

Evolus Corp - rincian analitis lan metrik utama (EOLS)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental:EOLS (Evolus, Inc.)
Produk dadi Jeuveau

This indicator compares the total enterprise value of the business to its annual revenue, excluding the impact of debt obligations. The EV/Revenue trend allows for the determination of the asset's overvaluation under inflationary pressure. A decrease in this ratio signals an increase in investment attractiveness. For Evolus, Inc. (EOLS), this parameter is critical due to the discretionary nature of demand for injections. The cyclicality of aesthetic medicine makes the valuation sensitive to economic cycles.

Analisis pesaing Evolus, Inc.

Multiplikator nilai perusahaan marang pendapatan hcahealthcare.com|THC: Multiplikator EV/Sales|FMS - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan SOLV|Encompass (EHC) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Universal Health Services, Inc. (UHS)|DaVita Inc. - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan RadNet Corp RDNT|Multiplikator EV/Sales Option Care OPCH|Surgery Partners Inc - Multiplikator EV/Sales|PINC (Premier Corp) - Rasio nilai perusahaan marang pendapatan|nationalvision.com (EYE) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Progyny|Nilai perusahaan marang pendapatan ARDT|Multiplikator EV/Sales Select Medical Corporation|Nilai perusahaan marang pendapatan ASTH (Astrana Health)|Nilai perusahaan marang pendapatan Pediatrix MD|U.S. Physical Therapy - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan PNTG|Organogenesis - Multiplikator EV/Sales|NUTX (Nutex Health) - Rasio nilai perusahaan marang pendapatan|AUNA (Auna) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan SBC (SBC Medical Group Holdings)|Rasio nilai perusahaan marang pendapatan chs.net|SKIN: Nilai bisnis marang pendapatan|Multiplikator EV/Sales MDWD|BTMD - Multiplikator nilai perusahaan marang pendapatan|The Joint Chiropractic - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan DCGO (DocGo, Inc)|Rasio total nilai perusahaan marang pendapatan PIII (p3hp.org)|GANX (Gain Therapeutics) - Rasio nilai perusahaan marang pendapatan|euda.com (EUDA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Basel Medical|CLGN (CollPlant Biotechnologies) - Multiplikator EV/Sales|Multiplikator EV/Sales Cuprina Holdings Limited|Rasio nilai perusahaan marang pendapatan concordmedical.com (CCM)|Rasio nilai perusahaan marang pendapatan AMS (American Shared Hospital)|Rasio nilai perusahaan marang pendapatan MEDIROM Corp MRM|Multiplikator EV/Sales avalon-globocare.com ALBT|DHAI - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan Longevity Health Holdings XAGE|NIVF (NewGenIvf Group Limited) - Nilai perusahaan marang pendapatan|ATI Physical Therapy Inc. - Nilai bisnis marang pendapatan|CMAX (caremax.com) - Multiplikator EV/Sales|KDLY (Kindly MD Inc) - Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ModivCare Corp (MODV)|Rasio total nilai perusahaan marang pendapatan Novo Integrated Sciences|SunLink Health Systems, Inc. - Nilai perusahaan marang pendapatan|imacholdings.comm (BACK) - Multiplikator nilai perusahaan marang pendapatan